Bayer enters into cancer immunotherapy collaboration with Compugen
10:41 AM | August 5, 2013 | Deepti Ramesh
Bayer says that its Bayer HealthCare subgroup has entered into an oncology collaboration and license agreement with drug discovery company Compugen (Tel Aviv, Israel). The partnership will focus on...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.